Evidence map›Paper›PMID 37704594›Full record

ArticleNature communications2023

Human OPRM1 and murine Oprm1 promoter driven viral constructs for genetic access to μ-opioidergic cell types.

Gregory J Salimando, Sébastien Tremblay, Blake A Kimmey, Jia Li, Sophie A Rogers, Jessica A Wojick, Nora M McCall, Lisa M Wooldridge, Amrith Rodrigues, Tito Borner and 15 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Central amygdalar PKCδ neurons mediate fentanyl withdrawal.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Opioid Receptors Modulate Inhibition within the Prefrontal Cortex through Dissociable Cellular and Molecular Mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  7. Article
  8. Article
  9. Mimicking opioid analgesia in cortical pain circuits.bioRxiv : the preprint server for biology · 2025
    Article
  10. VTA µ-Opioidergic Neurons Facilitate Low Sociability in Protracted Opioid Abstinence.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  11. Convergent state-control of endogenous opioid analgesia.bioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. Review
  14. Imaging Single-Cell CaBio-protocol · 2024
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 1 country.

Gregory J SalimandoDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Sébastien TremblayDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-6251-9797
Blake A KimmeyDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jia LiDept. of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Sophie A RogersDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jessica A WojickDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Nora M McCallDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Lisa M WooldridgeDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Amrith RodriguesTranslational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Tito BornerDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kristin L GardinerDept. of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Selwyn S JayakarF.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Ilyas SingeçStem Cell Translation Laboratory, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.ORCID http://orcid.org/0000-0003-3941-1838
Clifford J WoolfF.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6636-3897
Matthew R HayesDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-9782-6551
Bart C De JongheDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
F Christian BennettDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-2570-0620
Mariko L BennettDivision of Neurology, Dept. of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Julie A BlendyDept. of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-1705-9001
Michael L PlattDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kate Townsend CreasyTranslational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-1870-4586
William R RenthalDept. of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Charu RamakrishnanCNC Program, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-3474-6332
Karl DeisserothCNC Program, Stanford University, Stanford, CA, USA. deissero@stanford.edu.ORCID http://orcid.org/0000-0001-9440-3967
Gregory CorderDept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. gcorder@upenn.edu.
University of Pennsylvania · USBoston Children's Hospital · USBrigham and Women's Hospital · USChildren's Hospital of Philadelphia · USHoward Hughes Medical Institute · USNational Institutes of Health · USNeurosciences Institute · USStanford University · USTranslational Therapeutics (United States) · US

Funding

Unravelling Mechanisms and Novel Therapeutic Targets for Peripheral Neuropathy and Neuropathic Pain (Diversity Supplement)R35NS105076 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WOOLF, CLIFFORD J · 2018 to 2025
$9.5M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
Neural Circuit Mechanisms Mediating TMS and Oxytocin Effects on Social CognitionR37MH109728 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI PLATT, MICHAEL L · 2016 to 2025
$6.7M
T32 Translational Addiction Research Fellowship ProgramT32DA028874 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Julie A Blendy, Anna Rose Childress · 2010 to 2026
$5.0M
Neural Mechanisms of Nausea, Vomiting, and Energy DysregulationR01DK112812 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Bart C DE JONGHE, MATTHEW R HAYES · 2017 to 2026
$4.4M
Circuitry dynamics underlying opioid-dependence: Integrating structural, functional, and transcriptomic mechanismsR01DA056599 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI KEVIN T BEIER, Julie A Blendy · 2022 to 2026
$3.8M
Next Generation Gene Therapy for Refractory PainR01NS119476 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI William Russell Renthal · 2022 to 2026
$3.4M
Epigenomic labeling of cells that drive drug abuse behaviorDP1DA054343 · NIDA · BRIGHAM AND WOMEN'S HOSPITAL · PI RENTHAL, WILLIAM RUSSELL · 2021 to 2025
$2.7M
Targeting the GDF15-GFRAL system to treat nausea and emesisR01DK130239 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DE JONGHE, BART C, DOYLE, ROBERT P · 2021 to 2024
$2.7M
Harnessing cortical neuromodulation to disrupt pain perceptionDP2GM140923 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI CORDER, GREGORY · 2020 to 2022
$2.6M
Mapping opioid-dependence state transitions across structural, functional, and transcriptomic topologiesR01DA054374 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BLENDY, JULIE A, CORDER, GREGORY · 2021 to 2025
$2.4M
Deconstructing the network mechanisms of chronic pain and reward in the amygdalaR00DA043609 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CORDER, GREGORY · 2019 to 2021
$744k
NICHD NIH HHS P50 HD105351NIDA NIH HHS DP1 DA054343NIDA NIH HHS F31 DA057795NIDA NIH HHS F32 DA053099NIDA NIH HHS F32 DA055458NIDA NIH HHS R00 DA043609NIDA NIH HHS R01 DA054374NIDA NIH HHS R01 DA056599NIDA NIH HHS T32 DA028874NIDDK NIH HHS R01 DK112812NIDDK NIH HHS R01 DK130239NIGMS NIH HHS DP2 GM140923NIMH NIH HHS R37 MH109728NINDS NIH HHS F31 NS125927NINDS NIH HHS R01 NS119476NINDS NIH HHS R35 NS105076
6 · The paper itself

Abstract

With concurrent global epidemics of chronic pain and opioid use disorders, there is a critical need to identify, target and manipulate specific cell populations expressing the mu-opioid receptor (MOR). However, available tools and transgenic models for gaining long-term genetic access to MOR+ neural cell types and circuits involved in modulating pain, analgesia and addiction across species are limited. To address this, we developed a catalog of MOR promoter (MORp) based constructs packaged into adeno-associated viral vectors that drive transgene expression in MOR+ cells. MORp constructs designed from promoter regions upstream of the mouse Oprm1 gene (mMORp) were validated for transduction efficiency and selectivity in endogenous MOR+ neurons in the brain, spinal cord, and periphery of mice, with additional studies revealing robust expression in rats, shrews, and human induced pluripotent stem cell (iPSC)-derived nociceptors. The use of mMORp for in vivo fiber photometry, behavioral chemogenetics, and intersectional genetic strategies is also demonstrated. Lastly, a human designed MORp (hMORp) efficiently transduced macaque cortical OPRM1+ cells. Together, our MORp toolkit provides researchers cell type specific genetic access to target and functionally manipulate mu-opioidergic neurons across a range of vertebrate species and translational models for pain, addiction, and neuropsychiatric disorders.

Indexed as

AnalgesiaChronic PainInduced Pluripotent Stem CellsAnimalsHumansMacacaMiceRatsReceptors, OpioidReceptors, Opioid, muTransgenesOPRM1 protein, humanOprm protein, mouseReceptors, OpioidReceptors, Opioid, mu

Identifiers

PMID37704594
PMCPMC10499891
OpenAlexW4386723931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.